Answers are grounded in this paper and cite their sources.
Viral envelope glycoproteins promote viral infection by mediating the fusion of the viral membrane with the host-cell membrane. Structural and biochemical studies of two viral glycoproteins, influenza hemagglutinin and HIV-1 envelope protein, have led to a common model for viral entry. The fusion mechanism involves a transient conformational species that can be targeted by therapeutic strategies. This mechanism of infectivity is likely utilized by a wide variety of enveloped viruses for which similar therapeutic interventions should be possible.
No takes yet. Share an insight, caveat, or question.
Eckert et al. (2001) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: